Factor Delaying Intravenous Thrombolytic Treatment with Acute Ischemic Stroke Patients in Chonburi Hospital
Keywords:
Ischemic stroke, Factor delaying, thrombolysisAbstract
Objective: In acute ischemic stroke patients, AHA/ASA guideline recommends a door-to-needle time (DNT) of less than of 60 minutes from the time patients arrives at the emergency department to receive thrombolytic treatment. The purpose of this descriptive study is to explore the factors that result in in-hospital delay of thrombolytic treatment, rt-PA, in acute ischemic stroke patients at Chonburi hospital.
Material and methods: All patients with acute ischemic stroke that were treated with intravenous thrombolysis, 0.9 mg/kg alteplase, at Chonburi hospital from 1 July 2017 to 30 June 2019 were included. Medical record was retrospectively reviewed by a neurologist. Data of consecutive stroke patients were collected. Age, sex, other comorbidities, body weight, blood pressure, blood sugar, presence of early ischemic change on CT, the clinical location of the stroke, arrival time during regular work hours, arrival mode (private vehicle and ambulance) and stroke severity on admission as measured with the national institutes of Health Stroke Scale(NIHSS) score were extracted. Data analyses was done by multivariable logistic regression model to identify independent predictors of a delayed DNT. P <0.5 was considered statistically significant.
Result: A total 0f 227 patients were included in the study. Of those, 175 patients (77.1%) were treated within 60 minutes and 52 patients (22.9%)had a DNT >60 minutes. The overall median DNT was 47 minutes (interquartile range, 40-58). The median age was 61 years (interquartile range, 51-73). Patients with atrial fibrillation are 2.7 times more likely to have a delayed DNT compared to patients without any comorbidities. In addition, patients who arrived by private transport are 3.1 times more likely to have delayed DNT compared to walk-in patients when controlled for the remaining time before thrombolytic treatment and ASPECT score. Moreover, a delay in any of the steps tended to cause delay in other steps as well. For example, a 1-minute delay in the door-to-lab time caused a 0.7 times increased in DNT; a 1-minute delay in the door-to-CT time caused a 0.99 times increased in DNT; a 1-minute delay in the door-to-medical resident/neurologist caused a 0.87 increased in DNT; a 1-minute delay in the door-to-consent time caused a 0.96 increased in DNT.
Conclusion: The delay in the DNT can be caused by a delay in many steps in the process from patient arrival to consultation, neuroimaging, and treatment, etc. Identifying the details of each step, the limitations in each individual hospital, and finding and efficient way to carry out the treatment are the key to achieving a timely thrombolytic treatment in acute ischemic stroke patients.
Keywords: Ischemic stroke, Factor delaying, thrombolysis
References
Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. The Lancet Neurology. 2003;2(1):43-53.
Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurologic clinics. 2008;26(4):871-95, vii.
McCoy CE, Langdorf MI, Lotfipour S. American Heart Association/American Stroke Association Deletes Sections from 2018 Stroke Guidelines. West J Emerg Med. 2018;19(6):947-51.
Saver JL. Time is brain--quantified. Stroke. 2006;37(1):263-6.
Advani R, Naess H, Kurz MW. The golden hour of acute ischemic stroke. Scandinavian journal of trauma, resuscitation and emergency medicine. 2017;25(1):54.
Ebinger M, Kunz A, Wendt M, Rozanski M, Winter B, Waldschmidt C, et al. Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy. JAMA neurology. 2015;72(1):25-30.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418.
Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. Jama. 2000;283(9):1145-50.
Fonarow GC, Zhao X, Smith EE, Saver JL, Reeves MJ, Bhatt DL, et al. Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative. JAMA. 2014;311(16):1632-40.
Fonarow GC, Smith EE, Saver JL, Reeves MJ, Hernandez AF, Peterson ED, et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke. 2011;42(10):2983-9.
Van Schaik SM, Scott S, de Lau LML, Van den Berg-Vos RM, Kruyt ND. Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors. Cerebrovasc Dis Extra. 2015;5(2):75-83.
Mikulik R, Kadlecova P, Czlonkowska A, Kobayashi A, Brozman M, Svigelj V, et al. Factors influencing in-hospital delay in treatment with intravenous thrombolysis. Stroke. 2012;43(6):1578-83.
Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. Jama. 2000;283(23):3102-9.
Appleton JP, Sprigg N, Bath PM. Blood pressure management in acute stroke. Stroke and Vascular Neurology. 2016;1(2):72-82.
Mowla A, Doyle J, Lail NS, Rajabzadeh-Oghaz H, Deline C, Shirani P, et al. Delays in door-to-needle time for acute ischemic stroke in the emergency department: A comprehensive stroke center experience. Journal of the neurological sciences. 2017;376:102-5.
Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123(7):750-8.
Tai YJ, Weir L, Hand P, Davis S, Yan B. Does a 'code stroke' rapid access protocol decrease door-to-needle time for thrombolysis? Internal medicine journal. 2012;42(12):1316-24.
Sauser K, Levine DA, Nickles AV, Reeves MJ. Hospital variation in thrombolysis times among patients with acute ischemic stroke: the contributions of door-to-imaging time and imaging-to-needle time. JAMA neurology. 2014;71(9):1155-61.
Downloads
Published
Versions
- 2026-02-12 (2)
- 2021-01-16 (1)
Issue
Section
License
Copyright (c) 2020 Chonburi Hospital Journal-วารสารโรงพยาบาลชลบุรี

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพิ์เป็นลิขสิทธิ์ของวารสารโรงพยาบาลชลบุรี